Yang, Q., Puhm, F., Freissmuth, M., & Nanoff, C. (2017). Hyponatremia and V2 vasopressin receptor upregulation: A result of HSP90 inhibition. Cancer Chemother Pharmacol.
استشهاد بنمط شيكاغوYang, Qiong, Florian Puhm, Michael Freissmuth, و Christian Nanoff. "Hyponatremia and V2 Vasopressin Receptor Upregulation: A Result of HSP90 Inhibition." Cancer Chemother Pharmacol 2017.
MLA استشهادYang, Qiong, Florian Puhm, Michael Freissmuth, و Christian Nanoff. "Hyponatremia and V2 Vasopressin Receptor Upregulation: A Result of HSP90 Inhibition." Cancer Chemother Pharmacol 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.